K. Baker

发表

Prognostic significance of mucins in colorectal cancer with different DNA mismatch-repair status

J. Jass, L. Terracciano, I. Zlobec, 2006, Journal of Clinical Pathology.

Node-Negative Colorectal Cancer at High Risk of Distant Metastasis Identified by Combined Analysis of Lymph Node Status, Vascular Invasion, and Raf-1 Kinase Inhibitor Protein Expression

J. Jass, L. Terracciano, I. Zlobec, 2008, Clinical Cancer Research.

The Immunologic Functions of the Neonatal Fc Receptor for IgG

E. Fiebiger, S. Qiao, D. Roopenian, 2012, Journal of Clinical Immunology.

Neonatal Fc receptor for IgG (FcRn) regulates cross-presentation of IgG immune complexes by CD8−CD11b+ dendritic cells

E. Fiebiger, J. Andersen, S. Qiao, 2011, Proceedings of the National Academy of Sciences.

Hepatic FcRn regulates albumin homeostasis and susceptibility to hepatotoxins

Inger, J. Andersen, S. D. Jones, 2018 .

Proximal versus distal hyperplastic polyps of the colorectum: different lesions or a biological spectrum?

J. Jass, K. Baker, Y. Zhang, 2004, Journal of Clinical Pathology.

Colorectal cancer cells express functional cell surface‐bound TGFβ

J. Jass, K. Baker, P. Raut, 2007, International journal of cancer.

Nonimmune Functions of IgG and Albumin FcRn : The Architect Behind the Immune and

R. Blumberg, K. Baker, T. Rath, 2015 .

The short isoform of the CEACAM1 receptor in intestinal T cells regulates mucosal immunity and homeostasis via Tfh cell induction.

G. Gerber, H. Weiner, L. Bry, 2012, Immunity.

Biology of Gut Immunoglobulins

E. Fiebiger, W. Lencer, R. Blumberg, 2012 .

Immune and non-immune functions of the (not so) neonatal Fc receptor, FcRn

S. Qiao, W. Lencer, R. Blumberg, 2009, Seminars in Immunopathology.

Protective mucosal immunity mediated by epithelial CD1d and IL-10

A. Kaser, S. Snapper, S. Brand, 2014, Nature.

Regulation of Immune Responses by the Neonatal Fc Receptor and Its Therapeutic Implications

R. Blumberg, K. Baker, T. Rath, 2015, Front. Immunol..

Beyond IgA: the mucosal immunoglobulin alphabet

W. Lencer, R. Blumberg, K. Baker, 2010, Mucosal Immunology.

IgE/FcεRI-Mediated Antigen Cross-Presentation by Dendritic Cells Enhances Anti-Tumor Immune Responses.

Kutlu G. Elpek, S. Turley, E. Fiebiger, 2015, Cell reports.

An FcRn-dependent role for anti-flagellin immunoglobulin G in pathogenesis of colitis in mice.

S. Qiao, W. Lencer, R. Blumberg, 2009, Gastroenterology.

CEACAM1 on activated NK cells inhibits NKG2D‐mediated cytolytic function and signaling

O. Mandelboim, L. Lanier, Lanfen Chen, 2013, European journal of immunology.

CEACAM1 dampens antitumor immunity by down-regulating NKG2D ligand expression on tumor cells

O. Mandelboim, L. Lanier, Lanfen Chen, 2011, The Journal of experimental medicine.

Neonatal Fc Receptor: From Immunity to Therapeutics this access benefits you. Your matters

S. Qiao, W. Lencer, R. Blumberg, 2010 .

A homozygous PMS2 founder mutation with an attenuated constitutional mismatch repair deficiency phenotype

Michael J. McGuffin, S. Gruber, W. Foulkes, 2015, Journal of Medical Genetics.

Granuloma annulare associated with hypercalcemia secondary to hyperparathyroidism

K. Baker, K. Pehr, 2006, International journal of dermatology.

Bacteriophage Transcytosis Provides a Mechanism To Cross Epithelial Cell Layers

Barbara A. Bailey, F. Rohwer, T. Lithgow, 2017, mBio.

Loss of APAF-1 expression is associated with tumour progression and adverse prognosis in colorectal cancer.

J. Jass, L. Terracciano, I. Zlobec, 2007, European journal of cancer.

Cross-presentation of IgG-containing immune complexes

E. Fiebiger, W. Lencer, R. Blumberg, 2013, Cellular and Molecular Life Sciences.

Overexpression of the receptor for hyaluronic acid mediated motility is an independent adverse prognostic factor in colorectal cancer

J. Jass, L. Terracciano, I. Zlobec, 2006, Modern Pathology.

A homozygous PMS 2 founder mutation with an attenuated constitutional mismatch repair de fi ciency phenotype

S. Gruber, W. Foulkes, R. Hegele, 2015 .

Fc-fusion proteins and FcRn: structural insights for longer-lasting and more effective therapeutics

J. Dumont, S. Qiao, W. Lencer, 2015, Critical reviews in biotechnology.

Expression of FcRn receptor in placental tissue and its relationship with IgG levels in term and preterm newborns

R. Blumberg, K. Baker, R. Saranz, 2018, American journal of reproductive immunology.

A Critical Review on the Effect of Docosahexaenoic Acid (DHA) on Cancer Cell Cycle Progression

L. Postovit, C. Field, K. Baker, 2017, International journal of molecular sciences.

Role of APAF‐1, E‐cadherin and peritumoural lymphocytic infiltration in tumour budding in colorectal cancer

L. Terracciano, I. Zlobec, J. Jass, 2007, The Journal of pathology.

Immunoglobulin Transport and Immunoglobulin Receptors

R. Blumberg, C. Kaetzel, K. Baker, 2015 .

Neonatal Fc Receptor: From Immunity to Therapeutics

S. Qiao, W. Lencer, R. Blumberg, 2010, Journal of Clinical Immunology.

Hyperplastic polyposis and cancer of the colon with gastrinoma of the duodenum

W. Foulkes, J. Jass, K. Baker, 2006, Nature Clinical Practice Oncology.

Prognostic significance of the wnt signalling pathway molecules APC, β‐catenin and E‐cadherin in colorectal cancer—a tissue microarray‐based analysis

L. Terracciano, I. Zlobec, J. Jass, 2007, Histopathology.

Anti-tumor immunity in mismatch repair-deficient colorectal cancers requires type I IFN–driven CCL5 and CXCL10

A. Namdar, D. Schiller, K. Baker, 2021, The Journal of experimental medicine.

Control of CD1d-restricted antigen presentation and inflammation by sphingomyelin

T. Karlsen, A. Kaser, E. Melum, 2019, Nature Immunology.

Differential significance of tumour infiltrating lymphocytes in sporadic mismatch repair deficient versus proficient colorectal cancers: a potential role for dysregulation of the transforming growth factor-beta pathway.

J. Jass, L. Terracciano, I. Zlobec, 2007, European journal of cancer.

Comparing docosahexaenoic acid (DHA) concomitant with neoadjuvant chemotherapy versus neoadjuvant chemotherapy alone in the treatment of breast cancer (DHA WIN): protocol of a double-blind, phase II, randomised controlled trial

K. Courneya, J. Mackey, Sunita Ghosh, 2019, BMJ Open.

Vav‐1 expression correlates with NFκB activation and CD40‐mediated cell death in diffuse large B‐cell lymphoma cell lines

R. Sladek, A. Tzankov, S. Dirnhofer, 2010, Hematological oncology.

Antitumor immunity in dMMR colorectal cancers requires interferon-induced CCL5 and CXCL10

A. Namdar, D. Schiller, K. Baker, 2020, bioRxiv.

Organoids Provide an Important Window on Inflammation in Cancer

K. Baker, 2018, Cancers.

Loss of raf-1 kinase inhibitor protein expression is associated with tumor progression and metastasis in colorectal cancer.

J. Jass, L. Terracciano, I. Zlobec, 2007, American journal of clinical pathology.

RHAMM, p21 Combined Phenotype Identifies Microsatellite Instability-High Colorectal Cancers with a Highly Adverse Prognosis

L. Terracciano, I. Zlobec, A. Lugli, 2008, Clinical Cancer Research.

Advanced colorectal polyps with the molecular and morphological features of serrated polyps and adenomas: concept of a ‘fusion’ pathway to colorectal cancer

J. Jass, D. Buchanan, J. Young, 2006, Histopathology.

Linear Lichen Planopilaris of the Trunk: First Report of a Case

K. Baker, K. Pehr, 2006, Journal of cutaneous medicine and surgery.

Characterization of the immunological microenvironment of tumour buds and its impact on prognosis in mismatch repair‐proficient and ‐deficient colorectal cancers

L. Terracciano, I. Zlobec, A. Lugli, 2011, Histopathology.

Tumor border configuration added to TNM staging better stratifies stage II colorectal cancer patients into prognostic subgroups

L. Terracciano, I. Zlobec, A. Lugli, 2009, Cancer.

Dendritic cell-bound IgE functions to restrain allergic inflammation at mucosal sites

J. Kinet, E. Fiebiger, R. Blumberg, 2014, Mucosal Immunology.

Hepatic FcRn regulates albumin homeostasis and susceptibility to liver injury

J. Andersen, S. D. Jones, N. Kaplowitz, 2017, Proceedings of the National Academy of Sciences.

FcRn: The Architect Behind the Immune and Nonimmune Functions of IgG and Albumin

W. Lencer, R. Blumberg, K. Baker, 2015, The Journal of Immunology.

Prognostic significance of mammalian sterile20-like kinase 1 in colorectal cancer

J. Jass, L. Terracciano, I. Zlobec, 2007, Modern Pathology.

Role of the mitogen-activated protein kinase and phosphoinositide 3-kinase/AKT pathways downstream molecules, phosphorylated extracellular signal-regulated kinase, and phosphorylated AKT in colorectal cancer-a tissue microarray-based approach.

J. Jass, L. Terracciano, I. Zlobec, 2006, Human pathology.

Prognostic impact of β-2-microglobulin expression in colorectal cancers stratified by mismatch repair status

D. Baumhoer, I. Zlobec, V. Koelzer, 2012, Journal of Clinical Pathology.

Urokinase-type plasminogen activator is a marker of aggressive phenotype and an independent prognostic factor in mismatch repair-proficient colorectal cancer.

L. Terracciano, D. Baumhoer, I. Zlobec, 2010, Human pathology.

Multimarker phenotype predicts adverse survival in patients with lymph node‐negative colorectal cancer

J. Jass, L. Terracciano, D. Baumhoer, 2008, Cancer.

The Role of FcRn in Antigen Presentation

R. Blumberg, K. Baker, T. Rath, 2014, Front. Immunol..

FcRn is a CD32a coreceptor that determines susceptibility to IgG immune complex–driven autoimmunity

E. Fiebiger, J. Andersen, J. Glickman, 2020, The Journal of experimental medicine.

Prognostic significance of CD8+ T lymphocytes in breast cancer depends upon both oestrogen receptor status and histological grade

W. Foulkes, L. Terracciano, I. Zlobec, 2011, Histopathology.

Regulation of Immunological Responses by the Neonatal Fc Receptor for IgG, FcRn

R. Blumberg, K. Baker, T. Rath, 2013 .

Therapeutic implications of Src independent calcium mobilization in diffuse large B-cell lymphoma.

W. Foulkes, A. Tzankov, S. Dirnhofer, 2010, Leukemia research.

Neonatal Fc receptor expression in dendritic cells mediates protective immunity against colorectal cancer.

R. Odze, J. Glickman, C. Jobin, 2013, Immunity.

MSI-H colorectal cancers preferentially retain and expand intraepithelial lymphocytes rather than peripherally derived CD8+ T cells

W. Foulkes, J. Jass, K. Baker, 2008, Cancer Immunology, Immunotherapy.

TIA-1 Cytotoxic Granule-Associated RNA Binding Protein Improves the Prognostic Performance of CD8 in Mismatch Repair-Proficient Colorectal Cancer

L. Terracciano, A. Tzankov, I. Zlobec, 2010, PloS one.

Tumor Buds Show Reduced Expression of Laminin-5 Gamma 2 Chain in DNA Mismatch Repair Deficient Colorectal Cancer

H. Ueno, W. Foulkes, J. Jass, 2006, Diseases of the colon and rectum.

Transforming growth factor‐beta pathway disruption and infiltration of colorectal cancers by intraepithelial lymphocytes

W. Foulkes, J. Jass, K. Baker, 2006, Histopathology.

The Immunologic Functions of the Neonatal Fc Receptor for IgG

E. Fiebiger, S. Qiao, D. Roopenian, 2012, Journal of Clinical Immunology.

FAST TRACK Colorectal cancer cells express functional cell surface-bound TGFb

J. Jass, K. Baker, P. Raut, 2008 .

Neonatal Fc receptors for IgG drive CD8+ T cell-mediated anti-cancer immunosurveillance at tolerogenic mucosal sites

R. Blumberg, K. Baker, T. Rath, 2014, Oncoimmunology.

Two-marker protein profile predicts poor prognosis in patients with early rectal cancer

C. Beglinger, I. Zlobec, A. Lugli, 2008, British Journal of Cancer.

A simple, cost-effective method for generating murine colonic 3D enteroids and 2D monolayers for studies of primary epithelial cell function.

M. Stahl, W. MacNaughton, D. McKay, 2017, American journal of physiology. Gastrointestinal and liver physiology.

Microsatellite unstable colorectal cancer cell lines with truncating TGFbetaRII mutations remain sensitive to endogenous TGFbeta.

J. Jass, K. Baker, P. Raut, 2007, The Journal of pathology.

Short chain fatty acids prime colorectal cancer cells to activate antitumor immunity

K. Baker, Courtney Mowat, Ilsa Bhatti, 2023, Frontiers in Immunology.